Evox Therapeutics is a science-driven biotechnology company developing brain-targeted therapeutics. We aim to deliver growth by addressing significant unmet needs in severe and rare CNS diseases.
Sharing our conviction in the potential of our approach, Evox is supported by a blue-chip investor syndicate, which includes:
